NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot

Launched by ST. OLAVS HOSPITAL · Oct 16, 2024

Keywords

ClinConnect Summary

The NeoDoppler trial is studying a new ultrasound technology that helps doctors continuously monitor blood flow to the brain in very sick newborns and premature infants. This is important because understanding how blood is flowing can help in treating conditions like heart problems, infections, and other serious health issues. The trial is currently looking for participants, specifically healthy newborns or those with certain medical conditions, such as heart defects or infections. To be eligible, babies must have an open fontanelle (the soft spot on their head) and may need to be undergoing medical procedures.

If your baby is chosen to participate, they will be monitored using this new ultrasound technology in a non-invasive way, meaning no needles or surgery are involved. The goal is to gather important information that could improve how doctors care for sick newborns in the future. It's also important to note that caregivers must be able to understand either Norwegian or English and give their consent for their baby to participate. This trial could help pave the way for better monitoring tools in hospitals worldwide.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Open fontanelle
• • Healthy preterm or term born neonates
• • Neonates with a medical condition of interest according to the different cohort studies: patent ductus arteriosus, perinatal asphyxia, stroke, pulmonary hypertension, congenital heart condition or infection/sepsis/meningitis
• • Neonates in need of procedures
• Exclusion Criteria:
• • Caregivers not understanding/speaking Norwegian or English
• • Caregivers not giving their consent